Compare ARCT & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCT | SEVN |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.7M | 187.6M |
| IPO Year | 2019 | 2008 |
| Metric | ARCT | SEVN |
|---|---|---|
| Price | $7.31 | $8.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $24.11 | $10.50 |
| AVG Volume (30 Days) | ★ 382.0K | 83.3K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $82,031,000.00 | $29,383,000.00 |
| Revenue This Year | N/A | $27.75 |
| Revenue Next Year | $12.77 | $4.06 |
| P/E Ratio | ★ N/A | $44.26 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $7.90 |
| 52 Week High | $24.14 | $12.85 |
| Indicator | ARCT | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 49.78 |
| Support Level | $6.82 | $8.33 |
| Resistance Level | $7.94 | $8.83 |
| Average True Range (ATR) | 0.42 | 0.17 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 43.24 | 25.00 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.